Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
TCTN1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
GUSBP9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
ERVK13-1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NUMA1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PATZ1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DCAF7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TDP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
STAG3L3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMEM91 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KRT38 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZBTB46 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CLEC18A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SKIL - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ARHGEF40 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TK1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ESD - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ANKRD31 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on